Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > CFO just exercised

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jan 19, 2022 1:12pm

149 Views

Post# 34333551

RE:CFO just exercised

so did CEO. Date of expiry or maturity: 2022-02-27

Filed 2022-01-19 10:08 Tx date 2022-01-19	$SBM Sirona Biochem Corp.	Verrico, Howard Jarman 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$-79,999.84 -499,999 vol $0.16 each	0
Filed 2022-01-19 10:05 Tx date 2022-01-19	$SBM Sirona Biochem Corp.	Verrico, Howard Jarman 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	+500,000 vol	8,961,251
Filed 2022-01-19 10:02 Tx date 2022-01-19	$SBM Sirona Biochem Corp.	Hopton, Christopher 4 - Director of Issuer Direct Ownership	Warrants 54 - Exercise of warrants	$-40,000 -250,000 vol $0.16 each	0
Filed 2022-01-19 09:59 Tx date 2022-01-19	$SBM Sirona Biochem Corp.	Hopton, Christopher 4 - Director of Issuer Direct Ownership	Common Shares 54 - Exercise of warrants	+250,000 vol	1,228,525
Older filings